Abacus Wealth Partners »

Aurinia Pharmaceuticals shares owned by Abacus Wealth Partners

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Abacus Wealth Partners from 13F filings

Historical chart of Abacus Wealth Partners investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Abacus Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Abacus Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $367k 23k 15.95

More positions owned by Abacus Wealth Partners

Vert Global Sustainable Real Estate ETF Etf (VGSR)
DFA Dimensional Glbl Sustainability Fx Inc ETF Etf (DFSB)
Dimensional U S Targeted Value ETF Etf (DFAT)
Nuveen ESG Small-Cap ETF Etf (NUSC)
Adasina Social Justice All Cap Global ETF Etf (JSTC)
Dimensional US Sustainability Core 1 ETF Etf (DFSU)
Nuveen ESG Mid-Cap Value ETF Etf (NUMV)
Dimensional Intl Sustainability Core 1 ETF Etf (DFSI)
Nuveen ESG Emerging Markets Equity ETF Etf (NUEM)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Dimensional Emg Mkts Sustainability Core 1 ETF Etf (DFSE)
Microsoft Corp Common Stock (MSFT)
Dimensional Intern Small Cap VL ETF Etf (DISV)
Taiwan Semiconductor M F Common Stock (TSM)

View all positions for Abacus Wealth Partners

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Renaissance Technologies
Marshall Wace
Geode Capital Management
Jane Street
Vanguard Group
Two Sigma Investments
Nomura Holdings
Jacobs Levy Equity Management
Henderson Group
Goldman Sachs Group

View all funds holding Aurinia Pharmaceuticals